These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 8914885)

  • 21. Impact of metabolic syndrome on coronary patency after thrombolytic therapy for acute myocardial infarction.
    Yasar AS; Bilen E; Bilge M; Arslantas U; Karakas F
    Coron Artery Dis; 2009 Sep; 20(6):387-91. PubMed ID: 19696662
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Late activation of the fibrinolytic system in myocardial infarction treated with thrombolytic therapy. Influence of the coronary anatomical substrate.
    Salvioni A; Perego GB; Marenzi G; Lauri G; Giraldi F; Grazi S; Guazzi MD
    Eur Heart J; 1996 Feb; 17(2):230-6. PubMed ID: 8732376
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of results of intravenous infusion of anistreplase versus streptokinase in acute myocardial infarction.
    Vogt P; Monnier P; Schaller MD; Goy JJ; Beuret P; Essinger A; Bachmann F; Hauert J; Perret C; Sigwart U
    Am J Cardiol; 1993 Feb; 71(4):274-80. PubMed ID: 8427167
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Angiographic patency study of an albumin-free recombinant streptokinase formulation in acute myocardial infarction.
    Llerena LD; Quirós JJ; Sainz B; Valdés JA; Zorio B; Villanueva LH; Filgueiras CE; Cabrera F; Echarte JC; Pérez del Todo JM; Guerrero I; López L; García EJ; Nadal B; Betancourt BY; Díaz-Rojo G; García AI; López-Saura P
    J Pharm Pharm Sci; 2004 Nov; 7(3):372-7. PubMed ID: 15576019
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relation of coronary arterial patency and left ventricular function to electrocardiographic changes after streptokinase treatment during acute myocardial infarction.
    Richardson SG; Morton P; Murtagh JG; Scott ME; O'Keeffe DB
    Am J Cardiol; 1988 May; 61(13):961-5. PubMed ID: 3364381
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Evaluation of the effect of intravenous administration of streptokinase in acute myocardial infarction].
    Poloński L; Tendera M; Adamowicz E; Wodniecki J; Szczurek K; Wedrychowicz A
    Pol Arch Med Wewn; 1987; 77(1-2):16-24. PubMed ID: 3275388
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of pretreatment antistreptokinase antibody and streptococcal infection on the efficacy and dosage of streptokinase in acute myocardial infarction.
    Abuosa AM; Akhras F; Sorour K; El-Said G; El-Tobgy S; Kinsara AJ
    Saudi Med J; 2005 Jun; 26(6):934-6. PubMed ID: 15983677
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Double-blind, randomized, prospective comparison of loading doses of 600 mg clopidogrel versus 60 mg prasugrel in patients with acute ST-segment elevation myocardial infarction scheduled for primary percutaneous intervention: the ETAMI trial (early thienopyridine treatment to improve primary PCI in patients with acute myocardial infarction).
    Zeymer U; Mochmann HC; Mark B; Arntz HR; Thiele H; Diller F; Montalescot G; Zahn R
    JACC Cardiovasc Interv; 2015 Jan; 8(1 Pt B):147-154. PubMed ID: 25616919
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Status of the coronary arteries after thrombolytic therapy of myocardial infarction].
    Savchenko AP
    Klin Med (Mosk); 1991 Jan; 69(1):13-6. PubMed ID: 2023387
    [No Abstract]   [Full Text] [Related]  

  • 30. Significance of a coronary artery with thrombolysis in myocardial infarction grade 2 flow "patency" (outcome in the thrombolysis and angioplasty in myocardial infarction trials). Thrombolysis and Angioplasty in Myocardial Infarction Study Group.
    Lincoff AM; Topol EJ; Califf RM; Sigmon KN; Lee KL; Ohman EM; Rosenschein U; Ellis SG
    Am J Cardiol; 1995 May; 75(14):871-6. PubMed ID: 7732992
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-invasive detection of early infarct vessel patency by resolution of ST-segment elevation in patients with thrombolysis for acute myocardial infarction; results of the angiographic substudy of the Hirudin for Improvement of Thrombolysis (HIT)-4 trial.
    Zeymer U; Schröder R; Tebbe U; Molhoek GP; Wegscheider K; Neuhaus KL
    Eur Heart J; 2001 May; 22(9):769-75. PubMed ID: 11350109
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systemic versus intracoronary thrombolytic treatment in acute myocardial infarction.
    Verstraete M
    Acta Cardiol; 1985; 40(3):263-7. PubMed ID: 3895791
    [No Abstract]   [Full Text] [Related]  

  • 33. Time course of left ventricular function and coronary patency after saruplase vs streptokinase in acute myocardial infarction. The PRIMI Trial Study Group.
    Schofer J; Lins M; Mathey DG; Sheehan FH
    Eur Heart J; 1993 Jul; 14(7):958-63. PubMed ID: 8375422
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rate of fibrinogen breakdown related to coronary patency and bleeding complications in patients with thrombolysis in acute myocardial infarction--results from the PRIMI trial.
    Ostermann H; Schmitz-Huebner U; Windeler J; Bär F; Meyer J; van de Loo J
    Eur Heart J; 1992 Sep; 13(9):1225-32. PubMed ID: 1396833
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between admission mean platelet volume and coronary patency after thrombolytic therapy for acute myocardial infarction.
    Yaşar AS; Bilen E; Yüksel IO; Arslantaş U; Karakaş F; Kirbaş O; Bilge M
    Turk Kardiyol Dern Ars; 2010 Mar; 38(2):85-9. PubMed ID: 20473008
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A matched comparison of the combination of prehospital thrombolysis and standby rescue angioplasty with primary angioplasty.
    Juliard JM; Himbert D; Cristofini P; Desportes JC; Magne M; Golmard JL; Aubry P; Benamer H; Boccara A; Karrillon GJ; Steg PG
    Am J Cardiol; 1999 Feb; 83(3):305-10. PubMed ID: 10072213
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of lipoprotein-a on thrombolytic therapy and spontaneous reperfusion in acute myocardial infarction. A comparative study.
    Dagdelen S; Eren N; Akdemir I; Karabulut H; Ergelen M; Caglar N
    Int Angiol; 2002 Dec; 21(4):384-9. PubMed ID: 12518121
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of cigarette smoking on coronary patency after thrombolytic therapy for myocardial infarction. TEAM-2 Investigators. Second Multicenter Thrombolytic Trials of Eminase in Acute Myocardial Infarction.
    Gomez MA; Karagounis LA; Allen A; Anderson JL
    Am J Cardiol; 1993 Aug; 72(5):373-8. PubMed ID: 8352177
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Concomitant use of intraaortic balloon counterpulsation and streptokinase in acute anterior myocardial infarction.
    Kumbasar SD; Semiz E; Sancaktar O; Yalçinkaya S; Ermiş C; Değer N
    Angiology; 1999 Jun; 50(6):465-71. PubMed ID: 10378822
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Usefulness of recanalization to luminal diameter of 0.6 millimeter or more with intracoronary streptokinase during acute myocardial infarction in predicting "normal" perfusion status, continued arterial patency and survival at one year.
    Badger RS; Brown BG; Kennedy JW; Mathey D; Gallery CA; Bolson EL; Dodge HT
    Am J Cardiol; 1987 Mar; 59(6):519-22. PubMed ID: 3825888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.